AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 34(6), 1985, pp. 1022-1027
Copyright © 1985 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Webster, H. K.
Right arrow Articles by Boudreau, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Webster, H. K.
Right arrow Articles by Boudreau, E. F.

Cloning and Characterization of Mefloquine-Resistant Plasmodium Falciparum from Thailand

H. Kyle Webster, S. Thaithong*, K. Pavanand, K. Yongvanitchit, C. Pinswasdi* AND E. F. Boudreau
U.S. Army Medical Component, AFRIMS, Bangkok, Thailand
* Chulalongkorn University, Bangkok, Thailand

Resistance to mefloquine in Plasmodium falciparum has begun to occur along the border of Thailand and Kampuchea. As a means of assessing the natural occurrence of mefloquine resistance, the admission and post-treatment parasite isolates from a mefloquine treatment failure were cloned and characterized. Clones from the admission isolate were susceptible to mefloquine in vitro (ID50 of 3.4 [2–5], G [95% CI] ng/ml) and showed a mixture of isozyme types for glucose phosphate isomerase (GPI types I and II). The post-treatment clones were resistant to mefloquine in vitro (ID50 of 17.3 [13–23] ng/ml) with only one isozyme (GPI type I) detected. These observations suggest that under mefloquine pressure a resistant parasite population was selected in the patient, indicating that the potential for mefloquine resistance already exists in the indigenous P. falciparum gene pool. In addition, the mefloquine-resistant clones showed decreased susceptibility in vitro to halofantrine suggesting possible cross-resistance to this new antimalarial drug currently under development.

Accepted for publication June 24, 1985.




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
A. L. Pickard, C. Wongsrichanalai, A. Purfield, D. Kamwendo, K. Emery, C. Zalewski, F. Kawamoto, R. S. Miller, and S. R. Meshnick
Resistance to Antimalarials in Southeast Asia and Genetic Polymorphisms in pfmdr1
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2418 - 2423.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Martin, A. Oduola, and W. Milhous
Reversal of chloroquine resistance in Plasmodium falciparum by verapamil
Science, February 20, 1987; 235(4791): 899 - 901.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Society of Tropical Medicine and Hygiene.